Long-term secular trends in dermatomyositis and polymyositis mortality in the USA from 1981 to 2020 according to underlying and multiple cause of death mortality data

[1]  T. Lu,et al.  Impacts of using different standard populations in calculating age-standardised death rates when age-specific death rates in the populations being compared do not have a consistent relationship: a cross-sectional population-based observational study on US state HIV death rates , 2022, BMJ Open.

[2]  E. Yen,et al.  Trends in Systemic Sclerosis Mortality Over Forty‐Eight Years, 1968–2015: A US Population–Based Study , 2021, Arthritis Care & Research.

[3]  C. Crowson,et al.  Incidence, Prevalence, and Mortality of Dermatomyositis: A Population‐Based Cohort Study , 2021, Arthritis care & research.

[4]  Melonie P. Heron.  Deaths: Leading Causes for 2019. , 2021, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.

[5]  M. Bythell,et al.  P090 Validation of hospital episode statistics data to enable national registration of idiopathic inflammatory myopathies , 2021 .

[6]  J. Rosselló-Urgell,et al.  Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study , 2021, Journal of clinical medicine.

[7]  A. Ogdie,et al.  Persistent premature mortality gap in dermatomyositis and polymyositis: a United Kingdom general population-based cohort study. , 2020, Rheumatology.

[8]  Hyon K. Choi,et al.  Mortality trends in polymyositis and dermatomyositis: A general population-based study. , 2020, Seminars in arthritis and rheumatism.

[9]  E. Yen,et al.  Trends in Systemic Sclerosis Mortality Over Forty‐Eight Years, 1968–2015: A US Population–Based Study , 2020, Arthritis care & research.

[10]  J. Paik,et al.  Inflammatory muscle disease - An update. , 2020, Best practice & research. Clinical rheumatology.

[11]  Zhuoli Zhang,et al.  Mortality of Chinese patients with polymyositis and dermatomyositis , 2020, Clinical Rheumatology.

[12]  R. Misra,et al.  Infections Are Leading Cause of In-Hospital Mortality in Indian Patients With Inflammatory Myopathy. , 2019, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[13]  Katherine E Henson,et al.  Risk of Suicide After Cancer Diagnosis in England , 2018, JAMA psychiatry.

[14]  J. Simard,et al.  Do Death Certificates Underestimate the Burden of Rare Diseases? The Example of Systemic Lupus Erythematosus Mortality, Sweden, 2001-2013 , 2018, Public health reports.

[15]  Ning Li,et al.  46-Year Trends in Systemic Lupus Erythematosus Mortality in the United States, 1968 to 2013 , 2017, Annals of Internal Medicine.

[16]  G. C. Dobloug,et al.  Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study , 2017, Annals of the rheumatic diseases.

[17]  J. Silverberg,et al.  Validation of International Classification of Diseases Codes for the Epidemiologic Study of Dermatomyositis , 2017, Arthritis care & research.

[18]  J. Gran,et al.  Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort. , 2015, Seminars in arthritis and rheumatism.

[19]  I. Marie.  Morbidity and Mortality in Adult Polymyositis and Dermatomyositis , 2012, Current Rheumatology Reports.

[20]  J. M. Souza,et al.  Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis , 2010, BMC public health.

[21]  S. Walker,et al.  An international comparison study indicated physicians' habits in reporting diabetes in part I of death certificate affected reported national diabetes mortality. , 2005, Journal of clinical epidemiology.

[22]  J. Reveille,et al.  Lack of recording of systemic lupus erythematosus in the death certificates of lupus patients. , 2005, Rheumatology.

[23]  C. Helmick,et al.  Deaths from arthritis and other rheumatic conditions, United States, 1979-1998. , 2004, The Journal of rheumatology.

[24]  Hyune-Ju Kim,et al.  Kim H-J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351 , 2001 .

[25]  E. Feuer,et al.  Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.

[26]  A. Gittelsohn,et al.  Mortality from polymyositis and dermatomyositis in the United States, 1968-1978. , 1983, Arthritis and rheumatism.

[27]  Rascon.  [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.